How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,980 results for

Renin-Angiotensin System

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Blockade of the renin-angiotensin-aldosterone system in patients with arrhythmogenic right ventricular dysplasia: A double-blind, multicenter, prospective, randomized, genotype-driven study (BRAVE study). Full Text available with Trip Pro

Blockade of the renin-angiotensin-aldosterone system in patients with arrhythmogenic right ventricular dysplasia: A double-blind, multicenter, prospective, randomized, genotype-driven study (BRAVE study). Arrhythmogenic right ventricular dysplasia (ARVD) is a rare cardiomyopathy characterized by the progressive replacement of cardiomyocytes by fatty and fibrous tissue in the right ventricle (RV). These infiltrations lead to cardiac electrical instability and ventricular arrhythmia. Current

2018 Clinical cardiology Controlled trial quality: uncertain

122. Use of renin-angiotensin-aldosterone system inhibitors and risks of COVID-19

Use of renin-angiotensin-aldosterone system inhibitors and risks of COVID-19 Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2020 PROSPERO

123. Individual patient data meta-analysis of renin-angiotensin-aldosterone system inhibitors in COVID-19

Individual patient data meta-analysis of renin-angiotensin-aldosterone system inhibitors in COVID-19 Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2020 PROSPERO

124. The effects of renin-angiotensin-aldosterone system (RAAS) inhibitors on severity or mortality in patients with COVID-19: a meta-analysis

The effects of renin-angiotensin-aldosterone system (RAAS) inhibitors on severity or mortality in patients with COVID-19: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2020 PROSPERO

125. Renin Angiotensin System in Women Using Combined Oral Contraceptives

Renin Angiotensin System in Women Using Combined Oral Contraceptives Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2020 PROSPERO

126. Efficacy of the renin-angiotensin system inhibitors for hypertrophic cardiomyopathy: an meta-analysis

Efficacy of the renin-angiotensin system inhibitors for hypertrophic cardiomyopathy: an meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2020 PROSPERO

127. Efficacy of renin-angiotensin system inhibitors on the severity and risk of death in patients with hypertension for coronavirus disease 2019 (covid-19): a systematic review and meta-analysis

Efficacy of renin-angiotensin system inhibitors on the severity and risk of death in patients with hypertension for coronavirus disease 2019 (covid-19): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2020 PROSPERO

128. Renin-angiotensin-aldosterone system (RAAS) inhibitors and COVID-19 mortality in patients with hypertension hospitalized for COVID-19: a systematic review and meta-analysis

Renin-angiotensin-aldosterone system (RAAS) inhibitors and COVID-19 mortality in patients with hypertension hospitalized for COVID-19: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

129. Renin-angiotensin-aldosterone system (RAAS) inhibitor use and COVID-19 disease severity

Renin-angiotensin-aldosterone system (RAAS) inhibitor use and COVID-19 disease severity Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2020 PROSPERO

130. Comparative effectiveness of renin-angiotensin system inhibitors on renal and cardiovascular outcomes in patients with diabetes and kidney disease: a network meta-analysis

Comparative effectiveness of renin-angiotensin system inhibitors on renal and cardiovascular outcomes in patients with diabetes and kidney disease: a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

131. Impact of renin-angiotensin-aldosterone system inhibitors on mortality in hypertensive patients with COVID-19: systematic review and meta-analysis

Impact of renin-angiotensin-aldosterone system inhibitors on mortality in hypertensive patients with COVID-19: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2020 PROSPERO

132. A systematic review and meta-analysis of observational studies on the safety of renin-angiotensin system (RAS) blockers (angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs)) in relation to the likelihood of infection wi

A systematic review and meta-analysis of observational studies on the safety of renin-angiotensin system (RAS) blockers (angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs)) in relation to the likelihood of infection wi Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied

2020 PROSPERO

133. Association between early worsening renal function and following Outcomes in patients with renin angiotensin system inhibitors treatment: A Meta-Analysis

Association between early worsening renal function and following Outcomes in patients with renin angiotensin system inhibitors treatment: A Meta-Analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2020 PROSPERO

134. The tissue renin-angiotensin system (tRAS) and the impact of its inhibition on inflammation and bone loss in the periodontal tissue: A systematic review and network meta-analysis of animal studies

The tissue renin-angiotensin system (tRAS) and the impact of its inhibition on inflammation and bone loss in the periodontal tissue: A systematic review and network meta-analysis of animal studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2020 PROSPERO

135. The efficacy and safety of renin-angiotensin-aldosterone system inhibitors for the prevention or slowing of diabetic nephropathy in patients with diabetes: A meta-analysis study

The efficacy and safety of renin-angiotensin-aldosterone system inhibitors for the prevention or slowing of diabetic nephropathy in patients with diabetes: A meta-analysis study Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

136. Exposure to fine particulate matter in the air alters placental structure and the renin-angiotensin system. Full Text available with Trip Pro

Exposure to fine particulate matter in the air alters placental structure and the renin-angiotensin system. Female Wistar rats were exposed to filtered air (F) or to concentrated fine particulate matter (P) for 15 days. After mating, the rats were divided into four groups and again exposed to F or P (FF, FP, PF, PP) beginning on day 6 of pregnancy. At embryonic day 19, the placenta was collected. The placental structure, the protein and gene expression of TGFβ1, VEGF-A, and its receptor Flk-1

2017 PLoS ONE

137. The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients with Advanced Chronic Kidney Disease. Full Text available with Trip Pro

The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients with Advanced Chronic Kidney Disease. Renin-angiotensin-system (RAS) blockade is thought to slow renal progression in patients with chronic kidney disease (CKD). However, it remains uncertain if the habitual use of RAS inhibitors affects renal progression and outcomes in pre-dialysis patients with advanced CKD. In this multicenter retrospective cohort study, we identified 2,076 pre-dialysis

2017 PLoS ONE

138. Combined Inhibition of the Renin-Angiotensin System and Neprilysin Positively Influences Complex Mitochondrial Adaptations in Progressive Experimental Heart Failure. Full Text available with Trip Pro

Combined Inhibition of the Renin-Angiotensin System and Neprilysin Positively Influences Complex Mitochondrial Adaptations in Progressive Experimental Heart Failure. Inhibitors of the renin angiotensin system and neprilysin (RAS-/NEP-inhibitors) proved to be extraordinarily beneficial in systolic heart failure. Furthermore, compelling evidence exists that impaired mitochondrial pathways are causatively involved in progressive left ventricular (LV) dysfunction. Consequently, we aimed to assess

2017 PLoS ONE

139. Impact of renin-angiotensin system inhibitors on clinical outcomes and ventricular remodelling after transcatheter aortic valve implantation: rationale and design of the RASTAVI randomised multicentre study. Full Text available with Trip Pro

Impact of renin-angiotensin system inhibitors on clinical outcomes and ventricular remodelling after transcatheter aortic valve implantation: rationale and design of the RASTAVI randomised multicentre study. Transcatheter aortic valve implantation (TAVI) as a treatment in severe aortic stenosis (AS) is an excellent alternative to conventional surgical replacement. However, long-term outcomes are not benign. Renin-angiotensin system (RAS) blockade has shown benefit in terms of adverse

2018 BMJ open Controlled trial quality: uncertain

140. Individual variability in response to renin-angiotensin-aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: a primary care cohort study. Full Text available with Trip Pro

Individual variability in response to renin-angiotensin-aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: a primary care cohort study. To assess variability in systolic blood pressure (SBP) and albuminuria (urinary albumin creatinine ratio [UACR]) responses in patients with type 2 diabetes mellitus initiating renin angiotensin aldosterone system (RAAS) inhibition, and to assess the association of response variability with cardiovascular outcomes.We

2018 obesity & metabolism

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>